Dendritic cells are specialized immune cells whose primary job is to detect threats, collect evidence of those threats, and present that evidence to other immune cells so the body can mount a targeted response. First identified in mouse spleen tissue in the early 1970s by Ralph Steinman and Zanvil Cohn, they were named for their distinctive tree-like branches, or “dendrites,” that constantly extend and retract as the cells probe their surroundings.1PubMed Central. Kicking off adaptive immunity: the discovery of dendritic cells They are now understood as the primary bridge between the body’s fast but nonspecific first-line defenses and the slower, highly precise targeted immune response. That bridging role makes them central to nearly every immune event, from fighting infections to regulating allergies to determining whether cancer immunotherapy works.
How They Were Discovered
In the early 1970s, immunologists were trying to understand why certain substances triggered strong immune responses while others did not. During experiments to identify the “accessory” cells that helped boost immunity, Steinman and Cohn noticed unusual star-shaped cells in the spleens of mice. These cells behaved differently from anything previously cataloged. They had a unique ability to continuously form and retract branch-like projections, and when loaded with foreign material, they were far more effective at activating T cells than any other cell type tested.2PubMed. Dendritic cells: understanding immunogenicity The discovery eventually earned Steinman a Nobel Prize in 2011, though tragically he died just days before the announcement.
Where Dendritic Cells Come From
Dendritic cells originate in the bone marrow, arising from blood-forming stem cells through a tightly regulated developmental process.3PubMed Central. Dendritic cell development-History, advances, and open questions A key growth signal called Flt3 ligand drives the production of most dendritic cell populations found in steady-state tissues. Researchers have identified a shared precursor cell in the bone marrow that can give rise to both of the two main dendritic cell branches, confirming that the different subtypes share a common developmental origin before branching apart.4Nature Immunology. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow Once produced, these cells spread out to tissues throughout the body, stationing themselves wherever the body meets the outside world: skin, gut lining, lungs, and mucous membranes, as well as in lymph nodes and the spleen.
The Major Subtypes
Not all dendritic cells are the same. They come in several distinct flavors, each with a different specialty. The three main categories are conventional dendritic cells (split into two subtypes called cDC1 and cDC2), plasmacytoid dendritic cells, and monocyte-derived dendritic cells.
- cDC1: These are particularly good at a process called cross-presentation, where they take material from the external environment and display it to killer T cells. That makes them especially important for antiviral defense and for alerting the immune system to cancerous cells. They also promote strong pro-inflammatory responses and can activate natural killer cells.5PubMed Central. Human dendritic cell subsets: an update
- cDC2: These are broader in their reach. They can activate a wider range of helper T cells, including those involved in fighting bacteria, parasites, and fungi. No single master switch controls their development, which may explain their versatility.5PubMed Central. Human dendritic cell subsets: an update
- Plasmacytoid DCs: These cells are the body’s interferon factories. When they detect viral genetic material through specific sensors, they rapidly churn out large quantities of type I interferons, signaling proteins that put surrounding cells into an antiviral state and recruit reinforcements.6PubMed Central. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control
- Monocyte-derived DCs: These are not present in healthy tissues at rest. Instead, they form on demand during infections or inflammation, when circulating monocytes in the blood are activated and transform into dendritic cells at the site of trouble.7PubMed Central. Monocyte-Derived Dendritic Cell Differentiation in Inflammatory Arthritis Is Regulated by the JAK/STAT Axis via NADPH Oxidase Regulation They participate in both the quick innate response and the slower adaptive response.8PubMed. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation
Recent single-cell analysis has added nuance to this picture. What was once grouped under the cDC2 umbrella turns out to contain a distinct population now called DC3s, which share features of both conventional dendritic cells and monocytes but have their own gene expression signature and can be separated out using specific surface markers.9Immunity. Single-Cell RNA Sequencing and Lineage Analysis Redefine Human Dendritic Cell Heterogeneity This subdivision matters because DC3s appear to play a distinct role in tumor immunity: their infiltration into breast tumors correlates with the presence of tissue-resident memory T cells, a type of immune cell associated with better outcomes.9Immunity. Single-Cell RNA Sequencing and Lineage Analysis Redefine Human Dendritic Cell Heterogeneity A separate high-dimensional protein and RNA study confirmed an even broader heterogeneity, identifying inflammatory DC3 populations among circulating blood cells that had previously been missed.10Immunity. High-Dimensional Analysis Unravels Human-Circulating Myeloid Cell Phenotypes and Heterogeneity
How They Detect Threats and Sound the Alarm
Dendritic cells are covered in sensors collectively known as pattern recognition receptors. These sensors scan for molecular signatures commonly found on bacteria, viruses, fungi, and parasites but not on normal human cells. Two of the most studied families are Toll-like receptors and C-type lectin receptors, which detect everything from bacterial cell wall components to viral genetic material.11PubMed. Activation of dendritic cells by toll-like receptors and C-type lectins Another family of sensors, called NOD-like receptors, detects signals inside the cell and translates inflammatory triggers into productive T cell responses.12PubMed Central. Beyond pattern recognition: NOD-like receptors in dendritic cells
When these sensors fire, the dendritic cell undergoes a dramatic transformation. It shifts from a “surveillance” mode into an activated state, altering the expression of thousands of genes. This maturation program changes its surface molecules, its migratory behavior, and its ability to stimulate T cells.13Trends in Immunology. N/A A resting dendritic cell sitting in your skin is constantly sampling its environment but is not yet equipped to teach T cells anything useful. The activation step is what turns it from a passive observer into an active instructor.
Presenting Evidence to T Cells
The defining talent of dendritic cells is antigen presentation. After gobbling up foreign material, they break it into small fragments and display those fragments on their surface using specialized molecules. These surface displays come in two main varieties. One type presents fragments to helper T cells, which coordinate the broader immune response. Dendritic cells are among the few cell types that constitutively display these molecules, making them professional antigen-presenting cells alongside B cells and macrophages.14PubMed Central. The ins and outs of MHC class II-mediated antigen processing and presentation
The other display type communicates with killer T cells. Most cells use this pathway only to show fragments from their own internal proteins, which is how the immune system spots a cell that has been infected by a virus or has turned cancerous. Dendritic cells have a special trick here: they can take material they have picked up from the outside environment and load it onto this killer-cell display, a process called cross-presentation. This is critical because it allows dendritic cells to alert killer T cells about threats that the dendritic cell itself was never infected by.15PubMed Central. The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules Cross-presentation plays key roles in both fighting infections and recognizing tumors, and also in maintaining immune tolerance, preventing the immune system from attacking the body’s own healthy cells.16PubMed Central. Cross-presentation of exogenous antigens on MHC I molecules
Keeping the Peace Through Tolerance
Dendritic cells are not just warmongers. They also act as peacekeepers, actively preventing the immune system from attacking the body’s own tissues. A population known as tolerogenic dendritic cells does this through several mechanisms: they delete T cells that react against the body’s own proteins, they render self-reactive T cells unresponsive, and they promote the generation of regulatory T cells, which actively suppress inappropriate immune activity.17PubMed Central. Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity This balancing act is essential: too little dendritic cell activation and infections run rampant, too much and the immune system starts attacking the body itself.
When Dendritic Cells Drive Autoimmune Disease
Lupus is one of the clearest examples of what happens when dendritic cell regulation breaks down. In systemic lupus erythematosus, research has linked disease development to changes across the dendritic cell compartment, including altered numbers and locations of dendritic cell subsets and overactivation of both conventional and plasmacytoid types.18PubMed Central. Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools Plasmacytoid dendritic cells are thought to be central players here: their sustained, uncontrolled production of type I interferon leads to chronic inflammation and the widespread tissue damage characteristic of lupus.19Frontiers in Immunology. Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding High interferon levels are found in patients during disease flares, and the continuous activation of this interferon system, driven by both genetic and immunological factors, feeds a self-perpetuating cycle of autoimmune attack.20Revista Colombiana de Reumatología (English Edition). Dendritic cells and interferons in systemic lupus erythematosus
The very feature that makes plasmacytoid dendritic cells so valuable against viruses, their ability to pump out massive quantities of interferon, becomes a liability when that machinery cannot be turned off. This insight has shaped the development of lupus treatments that specifically target the interferon pathway.
How HIV Exploits Dendritic Cells
Pathogens have evolved their own strategies for subverting dendritic cells. HIV-1 provides a striking example. The virus binds to a surface molecule on dendritic cells called DC-SIGN, which under normal circumstances helps dendritic cells grab and internalize pathogens for processing. HIV hijacks this system: it latches onto DC-SIGN, and instead of being destroyed, the virus hitchhikes on the dendritic cell. When that dendritic cell then contacts a T cell (which is exactly what dendritic cells are designed to do), it hands over infectious virus in a process called trans-infection. Experiments showed that HIV capture was completely DC-SIGN dependent, since antibodies that blocked DC-SIGN prevented the virus from being transmitted.21Cell. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances Infection in Trans In other words, the virus turns the immune system’s own courier service into a delivery mechanism.
Dendritic Cell Vaccines in Cancer Treatment
Because dendritic cells are so effective at instructing T cells, researchers have spent decades trying to harness them for cancer therapy. The idea is straightforward: take dendritic cells, load them with tumor-associated material, and inject them back into a patient so they teach the immune system to recognize and destroy cancer cells. This approach has been explored in blood cancers like acute myeloid leukemia as well as solid tumors, using various sources of tumor material, from specific protein fragments to whole tumor cell preparations to RNA-based approaches.22PubMed Central. Research progress on dendritic cell vaccines in cancer immunotherapy
The technology for making these vaccines has grown more sophisticated over time, progressing from simply pulsing dendritic cells with protein fragments to genetic modification techniques and strategies that fuse dendritic cells with tumor cells to create hybrid vaccines.23Genes & Diseases. Dendritic cell vaccines: Current research progress, challenges, and opportunities Despite this progress, the honest picture is mixed: the percentage of patients who experience meaningful benefit from dendritic cell vaccines alone remains relatively low, and much of the current research focuses on combining them with other treatments like chemotherapy, targeted antibodies, or checkpoint inhibitors to boost their performance.24PubMed. Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy
Why Dendritic Cells Matter for Checkpoint Immunotherapy
One of the more surprising recent findings is that dendritic cells are a key reason why PD-L1 checkpoint blockade immunotherapy works at all. Checkpoint inhibitors, which have transformed treatment for cancers like melanoma and lung cancer, were originally developed based on the idea that they primarily reactivate exhausted T cells. But research has shown that dendritic cells are an important direct target of PD-L1 blocking antibodies. In patients with kidney cancer or lung cancer treated with the checkpoint inhibitor atezolizumab, a gene signature associated with dendritic cells was strongly linked to improved survival.25PubMed. Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
Animal experiments made the point even more sharply. When researchers deleted PD-L1 specifically from dendritic cells in mice, tumors no longer responded to PD-L1 blockade therapy at all. And mice that lacked the cDC1 subset entirely, the cross-presenting subtype, also failed to benefit from checkpoint blockade, with very few killer T cells found inside their tumors.26Nature Communications. PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade The implication is that checkpoint therapy does not just take the brakes off T cells; it reinvigorates dendritic cells so they can properly prime T cells in the first place. This understanding is reshaping how researchers think about why some patients respond to immunotherapy and others do not.
Langerhans Cells in the Skin
Your skin hosts its own resident dendritic cell population called Langerhans cells. These cells form an interconnected network in the outer layer of the skin and in mucosal surfaces like the lining of the mouth and reproductive tract, where they serve as front-line sentinels. What makes them unusual among immune cells is their remarkable self-sufficiency. Unlike most dendritic cells, which are continuously resupplied from bone marrow precursors, Langerhans cells maintain their numbers through local self-renewal, dividing in place without needing replenishment from the blood.27Frontiers in Immunology. Uncovering the Mysteries of Langerhans Cells, Inflammatory Dendritic Epidermal Cells, and Monocyte-Derived Langerhans Cell-Like Cells in the Epidermis They are also resistant to radiation, unlike most other immune cells. Studies on human tissue allografts have confirmed that human Langerhans cells renew themselves in the skin through cell division of preexisting cells under near-normal conditions.28PubMed. Self-renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft This self-sustaining quality means your skin’s immune surveillance network can persist for decades with minimal outside input.
The Metabolic Switch That Powers Activation
When dendritic cells detect a pathogen and flip into their activated state, they do not just change their surface molecules. They fundamentally rewire their internal energy metabolism. Research in mouse dendritic cells showed that activation through pattern recognition receptors triggers a sharp shift toward a type of rapid sugar-burning metabolism strikingly similar to the metabolic pattern used by cancer cells, sometimes called the Warburg effect.29PubMed Central. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation This switch makes intuitive sense: a dendritic cell that has just detected a threat needs to rapidly produce new surface molecules, manufacture signaling proteins, and physically migrate to a lymph node. All of that requires a burst of biosynthetic activity that the cell’s resting metabolism cannot support. Understanding this metabolic rewiring has opened a new area of research exploring whether manipulating dendritic cell metabolism could enhance their function in vaccine settings or dampen it in autoimmune contexts.